SLV-342

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSLV-342
Drug Alias NameSLV342SLV 342
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytoplasmic and nuclear receptors modulators
TargetsCytoplasmic and nuclear receptors
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A